tranexamic acid has been researched along with Carcinoma, Ovarian Epithelial in 2 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
Carcinoma, Ovarian Epithelial: A malignant neoplasm that originates in cells on the surface EPITHELIUM of the ovary and is the most common form of ovarian cancer. There are five histologic subtypes: papillary serous, endometrioid, mucinous, clear cell, and transitional cell. Mutations in BRCA1, OPCML, PRKN, PIK3CA, AKT1, CTNNB1, RRAS2, and CDH1 genes are associated with this cancer.
| Excerpt | Relevance | Reference |
|---|---|---|
| "High-dose tranexamic acid is more effective in reducing blood loss and blood transfusion without increasing the risk of postoperative complications." | 5.69 | Intraoperative use of tranexamic acid to reduce blood loss during cytoreductive surgery for advanced ovarian cancer: A randomized controlled clinical trial. ( Chai, M; He, Z; Wu, X; Xia, L; Yang, X; Zhang, J, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yang, X | 1 |
| Chai, M | 1 |
| Xia, L | 1 |
| He, Z | 1 |
| Wu, X | 1 |
| Zhang, J | 1 |
| Lemoine, A | 1 |
| Lambaudie, E | 1 |
| Bonnet, F | 1 |
| Leblanc, E | 1 |
| Alfonsi, P | 1 |
1 review available for tranexamic acid and Carcinoma, Ovarian Epithelial
| Article | Year |
|---|---|
[Perioperative care of epithelial ovarian cancer: Article drafted from the French Guidelines in oncology entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY under the aegis of CNGOF a
Topics: Analgesia, Patient-Controlled; Anemia; Antifibrinolytic Agents; Blood Loss, Surgical; Carcinoma, Ova | 2019 |
1 trial available for tranexamic acid and Carcinoma, Ovarian Epithelial
| Article | Year |
|---|---|
Intraoperative use of tranexamic acid to reduce blood loss during cytoreductive surgery for advanced ovarian cancer: A randomized controlled clinical trial.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Carcinoma, Ovarian Epithelial; Cytoreduction Surgical | 2023 |